The Global Lactulose Concentrate Syrup Market was valued at USD 152 million in 2023 and is projected to reach USD 218.22 million by 2032, growing at a Compound Annual Growth Rate (CAGR) of 4.10% during the forecast period (2023-2032). This expansion is driven by rising global incidence of digestive disorders, expanding applications in liver disease treatment, and increasing demand from pharmaceutical and food industries.

As healthcare providers and consumers increasingly recognize lactulose’s dual benefits as medical treatment and prebiotic supplement, manufacturers are innovating production processes and expanding therapeutic applications. This analysis profiles the Top 10 Companies Shaping the Lactulose Concentrate Syrup Market, featuring pharmaceutical innovators and specialized biochemical producers.

---

🔟 1. Abbott Laboratories

Headquarters: Illinois, USA
Key Offering: Clinical-grade lactulose syrups (Duphalac® brand)

A global healthcare leader, Abbott dominates the branded lactulose market with its FDA-approved Duphalac® formulations prescribed for chronic constipation and hepatic encephalopathy management worldwide.

Competitive Advantages:

• Proprietary purification processes ensuring product consistency
• Extensive clinical trial database supporting efficacy claims
• Direct-to-pharmacy distribution in 100+ markets

Download FREE Sample Report: Lactulose Concentrate Syrup Market – View in Detailed Research Report

---

9️⃣ 2. Morinaga Milk Industry Co., Ltd.

Headquarters: Tokyo, Japan
Key Offering: Ultra-pure lactulose (70% concentration)

Japan’s leading dairy science company applies advanced enzymatic technologies to produce high-grade lactulose meeting both pharmaceutical and nutraceutical specifications.

Competitive Advantages:

• Dedicated lactulose production facilities in Asia
• Special expertise in pediatric formulations
• Strict adherence to JP pharmacopeia standards

---

8️⃣ 3. Solactis Group

Headquarters: Saint-Lô, France
Key Offering: Pharmaceutical bulk lactulose (66%/70%)

This European biochemical specialist operates one of the continent’s largest dedicated lactulose production plants supplying GMP-certified material to drug manufacturers.

Competitive Advantages:

• Closed-loop manufacturing reducing impurities
• Custom concentration formulations
• Technical support for formulation development

---

7️⃣ 4. Fresenius Kabi

Headquarters: Bad Homburg, Germany
Key Offering: Hospital-formulated lactulose products

A leader in clinical nutrition, Fresenius Kabi provides sterile-packaged lactulose solutions specifically designed for institutional healthcare settings.

Competitive Advantages:

• Ready-to-administer formats for critical care
• Integrated dosing systems
• Global hospital distribution network

---

6️⃣ 5. Illovo Sugar Africa

Headquarters: Durban, South Africa
Key Offering: Cost-optimized lactulose syrup

Leveraging Africa’s abundant sugar cane resources, Illovo has developed efficient lactulose production capabilities serving price-sensitive markets.

Competitive Advantages:

• Full vertical integration from raw material to finished product
• Strategic partnerships with African healthcare providers
• Flexible packaging options

Download FREE Sample Report: Lactulose Concentrate Syrup Market – View in Detailed Research Report

---

5️⃣ 6. Biofac A/S

Headquarters: Køge, Denmark
Key Offering: EU-GMP compliant lactulose

This Scandinavian manufacturer supplies ultra-purified lactulose to European pharmaceutical companies with exceptionally low endotoxin levels.

Competitive Advantages:

• Specialization in pediatric-friendly formulations
• Cold-chain distribution capabilities
• Documentation meeting stringent EMA requirements

---

4️⃣ 7. Dandong Kangfu Pharmaceutical

Headquarters: Liaoning, China
Key Offering: High-volume lactulose API

As China’s largest lactulose active pharmaceutical ingredient producer, Dandong Kangfu supplies domestic and international generic drug manufacturers.

Competitive Advantages:

• Mass production capability (>10,000 tons annually)
• Competitive pricing structure
• Complete supply chain control

---

3️⃣ 8. Jiangsu Hi-stone Pharmaceutical

Headquarters: Jiangsu, China
Key Offering: Integrated lactulose solutions

Hi-stone combines API production with finished dosage manufacturing, offering turnkey solutions for lactulose-based medicines.

Competitive Advantages:

• Single-source API to finished product capability
• CFDA-certified manufacturing facilities
• Patented purification technologies

---

2️⃣ 9. Merro Pharmaceutical

Headquarters: Hubei, China
Key Offering: Advanced lactulose formulations

Merro focuses on innovative delivery systems and combination products enhancing lactulose’s therapeutic applications.

Competitive Advantages:

• Specialized modified-release technologies
• Flavor-masking expertise
• Compatibility with automated dispensing systems

---

1️⃣ 10. DKSH Healthcare

Headquarters: Zurich, Switzerland
Key Offering: Distribution and market access services

As Asia’s leading market expansion services provider, DKSH facilitates lactulose product distribution across complex emerging markets.

Competitive Advantages:

• Regulatory expertise across 20+ APAC markets
• Established hospital and pharmacy networks
• Quality assurance programs tailored to local requirements

Get Full Report Here: Lactulose Concentrate Syrup Market – View in Detailed Research Report

---

🌍 Market Outlook: Expanding Applications in Digestive Healthcare

The lactulose concentrate syrup market shows strong growth fundamentals, with increasing recognition of its therapeutic benefits beyond traditional constipation treatment.

📈 Key Industry Trends:

• Rising hepatic encephalopathy treatment adoption in developing nations
• Expanding geriatric population driving chronic constipation management needs
• Growing prebiotic food and beverage applications
• Emerging markets infrastructure development improving healthcare access

Get Full Report Here: Lactulose Concentrate Syrup Market – View in Detailed Research Report